Comstock Resources Enters Joint Development Agreement

Comstock Resources Enters Joint Development Agreement

Comstock Resources, an energy exploration and production company, said Monday it has entered into a joint development venture with USG Properties that will target Haynesville shale in Louisiana and Texas. The agreement relates to acreage recently been acquired by USG. Comstock will operate the wells and will manage the drilling program in exchange for a 12.5% working interest in the acreage. Under the terms of the arrangement Comstock can acquire […]

Read More ˃
Foundation Medicine Appoints Troy Cox as CEO

Foundation Medicine Appoints Troy Cox as CEO

Foundation Medicine, a molecular information company, appointed Troy Cox, as chief executive officer to succeed Michael Pellini, M.D. Dr. Pellini, who has served as chief executive officer of the company since 2011, has been appointed chairman of the company’s board of directors. All of these changes will become effective by Feb. 6. Cox joins Foundation Medicine from Roche-Genentech, where he led one of the largest oncology portfolios in the U.S., […]

Read More ˃
Ducommun Names Stephen G. Oswald as New CEO

Ducommun Names Stephen G. Oswald as New CEO

Ducommun, a global provider of engineering and manufacturing services, said late Thursday that Stephen G. Oswald will join the company as Ducommun’s new chief executive officer effective Jan. 23, 2017. Oswald was previously CEO of Capital Safety and a senior executive at United Technologies Corporation (UTX). Anthony J. Reardon will relinquish his current operational duties but continue as executive chairman of Ducommun. Reardon and Oswald will be members of the […]

Read More ˃
TG Therapeutics Launches Phase 2 Study

TG Therapeutics Launches Phase 2 Study

TG Therapeutics announced an investigator-initiated second phase study evaluating the safety and efficacy of TGR-1202 in combination with ibrutinib in treating relapsed or refractory Diffuse Large B-cell Lymphoma. The study, conducted at the University of Nebraska Medical Center, will also explore correlative analyses related to the combination. The company and its partner Janssen Pharmaceuticals will each provide drug and equally share study-related costs.

Read More ˃
NexPoint Residential Trust Completes Houston Property Acquisition

NexPoint Residential Trust Completes Houston Property Acquisition

NexPoint Residential Trust has completed its acquisition of the 924-unit apartment portfolio in Houston, Texas for $108 million. The acquisition was structured as a reverse 1031 exchange to facilitate the company’s continued plan to recycle capital from dispositions of assets from non-core markets into well-located assets in longer-term target markets. The acquisition was funded with borrowings of approximately $108 million under its credit facilities with KeyBank National Association (KEY) and […]

Read More ˃